BioSpace News Archive

Deals

Mirati Therapeutics Announces Proposed Public Offering of Common Stock - Jan. 8, 2020

Mirati Therapeutics, Inc. announced that it intends to offer and sell, subject to market and other conditions, $250.0 million of shares of its common stock in an underwritten public offering.

January 8, 2020
·
4 min read
Biotech Bay

Akero Therapeutics To Present At The 2020 J.P. Morgan Healthcare Conference

J.P. Morgan Healthcare Conference at 7:30 AM Pacific time on Wednesday, January 15, 2020.

January 8, 2020
·
1 min read
Genetown

Vertex to Present at the J.P. Morgan Healthcare Conference on January 13

The audio portion of management’s remarks can be accessed live through Vertex’s website, www.vrtx.com, in the “Investors” section under the “News and Events” page.

January 8, 2020
·
1 min read
Business

AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2020 Earnings Release

The Company will host a conference call to discuss the results at 8:30 a.m. ET on January 30, 2020.

January 8, 2020
·
2 min read
Business

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

Full year 2019 sales are expected to be approximately $784.7 million, an increase of 10.1% over the prior year.

January 8, 2020
·
9 min read
FDA

FDA Approves Merck’s KEYTRUDA® for Patients With BCG-Unresponsive, High-Risk, Non-Muscle Invasive Bladder Cancer With Carcinoma In Situ With or Without Papillary Tumors Who Are Ineligible for or Have Elected Not to Undergo Cystectomy

KEYTRUDA Is the First Anti-PD-1 Therapy Approved for Certain Patients With High-Risk, Non-Muscle Invasive Bladder Cancer

January 8, 2020
·
34 min read
Business

Quest Diagnostics To Release Fourth Quarter And Full Year 2019 Financial Results On January 30

Quest Diagnostics Incorporated, the world’s leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2019 results on Thursday, January 30, 2020, before the market opens.

January 8, 2020
·
1 min read